Wednesday, August 17, 2022
Home Tags MIPS

Tag: MIPS

IDT announces successful manufacture of Australia’s first mRNA COVID-19 vaccine candidate

It took just five months for Victorian scientists and manufacturers to develop Australia's first mRNA COVID-19 vaccine candidate — the country's first ever mRNA medicinal product – allowing...

IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...

Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...

IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate

Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...

Monash awarded $5m grant to manufacture Australia’s first COVID-19 vaccine candidate

The Monash Institute of Pharmaceutical Sciences (MIPS) has received $5 million from the Victorian Government to manufacture doses of Australia’s first COVID-19 vaccine candidate...

Industry partnership yields high recognition

The Monash Institute of Pharmaceutical Sciences (MIPS) has received high recognition for the Monash-GSK Australian Center for Innovation and Industrialization Project aimed at developing...
Advertisement

Redback Lasers

Featured Article

How to transform your operation into a smart factory: Building intelligent applications

The Australian manufacturing industry is fast entering the era of Industry 4.0. Harnessing the latest technology and transforming your operation into a smart factory is vital to building resilience, and optimising productivity and operational efficiency. And with the right help, it’s easier than you might think.